---
created: 2025-04-13
updated: 2025-04-13T10:52
id: Fp+Fu:E3Ot
specialty: pharmaco
specialty_id: 322
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::06-other-cancer-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::trastuzumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::26-trastuzumab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::29-key-chemotoxicities
  - "source/ak-step1-v11:": 
  - theme/ome::06-inflammation-neoplasia::08-cycle-chemo
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::22-onc-drugs::19-trastuzumab
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::trastuzumab
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::02-rituximab,-cetuximab,-bevacizumab,-alemtuzumab,-trastuzumab::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::14000-14999::14844
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Is the heart failure associated with Trastuzumab reversible with treatment discontinuation?   **Yes**

---

# Answer
since HER2 helps preserve cardiomyocyte function == decrease in myocardial contractility W/O cardiomyocyte destruction or myocardial fibrosis  - This is reversible with treatment discontinuation